000 01198 a2200337 4500
005 20250515051911.0
264 0 _c20070403
008 200704s 0 0 eng d
022 _a0968-0896
024 7 _a10.1016/j.bmc.2006.12.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRawal, Ravindra K
245 0 0 _aDesign, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry
_cFeb 2007
300 _a1725-31 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnti-HIV Agents
_xchemical synthesis
650 0 4 _aCell Line
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDrug Design
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHumans
650 0 4 _aThiazolidines
_xchemical synthesis
700 1 _aTripathi, Rajkamal
700 1 _aKatti, S B
700 1 _aPannecouque, Christophe
700 1 _aDe Clercq, Erik
773 0 _tBioorganic & medicinal chemistry
_gvol. 15
_gno. 4
_gp. 1725-31
856 4 0 _uhttps://doi.org/10.1016/j.bmc.2006.12.003
_zAvailable from publisher's website
999 _c16746039
_d16746039